- Document Type
- Table
- Review Code
- EOC062201v2 RR Table
- Question Submitted
- June 22, 2020
- Date Completed
- January 22, 2021
- Status
- 5. Updated review
- Research Team
- EOC
- Document Type
- Table
- Review Code
- EOC062201v2 RR Table
- Question Submitted
- June 22, 2020
- Date Completed
- January 22, 2021
- Status
- 5. Updated review
- Research Team
- EOC
- Category
- Clinical Presentation
- Subject
- Chemotherapy
- Cancer
- Comorbidities
- Natural History
- Population
- All
- Priority Level
- Level 3 completed within 2-3 days
- Cite As
- Vanstone, J; Groot, G; Miller, L; Mueller, M. What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? 2021 Jan 22; Document no.: EOC062201v2 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 5 p. (CEST table)
- Review History
- EOC062201 RR: June 29, 2020
Related Documents
Less detail
